A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow
Launched by MEDICAL UNIVERSITY OF VIENNA · Dec 5, 2007
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6 healthy volunteers of either sex
- • Age 18-35 yrs.
- • Body mass index between 15th and 85th percentile, nonsmokers
- Exclusion Criteria:
- • Regular use of medication
- • Abuse of alcoholic beverages or drugs
- • Participation in a clinical trial in the 3 weeks preceding the study
- • Treatment in the previous 3 weeks with any drug
- • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
- • History or presence of gastrointestinal, liver or kidney disease, or other conditions known to interfere with distribution, metabolism or excretion of study drugs
- • Blood donation during the previous 3 weeks
- • Ametropy less 3 dpt
- • Acute gastric bleeding, massive cerebral hemorrhage related to stroke
- • Women: pregnancy or lactation.
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Michael Wolzt, Prof
Principal Investigator
Department of Clinical Pharmacology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials